AI in Patient Engagement Market Outlook:
AI in Patient Engagement Market size was over USD 7.86 billion in 2025 and is poised to exceed USD 46.29 billion by 2035, growing at over 19.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of AI in patient engagement is evaluated at USD 9.23 billion.
Key AI in Patient Engagement Market Insights Summary:
Regional Highlights:
- North America commands a 38.5% share in the AI in Patient Engagement market, driven by the growing demand for personalized healthcare and technological advancements, enhancing patient outcomes through 2026–2035.
- Europe is projected to experience the fastest growth in the AI in Patient Engagement Market from 2026 to 2035, driven by regulatory frameworks enhancing AI adoption and patient engagement.
Segment Insights:
- The Cloud-based segment is forecasted to generate significant revenue by 2035, attributed to its ability to streamline operations and improve patient interactions.
- The Enhanced Communication segment is expected to secure over 34.3% market share by 2035, driven by the transformation of patient-provider communication using AI.
Key Growth Trends:
- Growing adoption of telemedicine and digital health tools
- Rising prevalence of chronic diseases
Major Challenges:
- High implantation and integration costs
- Lack of standardization
- Key Players: Innovaccer, Inc, EnlivenHealth (a subdivision of Omnicell, Inc.), EmpiRx Health, LLC., IBM, Huma, mPulse Mobile, and AllazoHealth.
Global AI in Patient Engagement Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 7.86 billion
- 2026 Market Size: USD 9.23 billion
- Projected Market Size: USD 46.29 billion by 2035
- Growth Forecasts: 19.4% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: North America (38.5% Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, China, Germany, United Kingdom, Japan
- Emerging Countries: China, India, Japan, South Korea, Singapore
Last updated on : 14 August, 2025
The primary growth driver is the increasing demand for personalized and efficient patient care. According to a survey by Rendia, Inc.,72% of patients stated they want more personalized care that is tailored to their specific clinical needs, and the majority believe that technology is the solution. Patients expect healthcare experiences tailored to their individual needs. AI technologies enable healthcare providers to analyze patient data, preferences, and behavior, facilitating personalized communication and interventions.
AI enhances patient engagement by providing tools that support better health management. Solutions such as reminders for medication adherence, personalized health recommendations, and educational content improve patient adherence to treatment plans and overall health outcomes.
AI in Patient Engagement Market Growth Drivers and Challenges:
Growth Drivers
- Growing adoption of telemedicine and digital health tools: Telemedicine allows patients to access healthcare services remotely, which is especially important in rural or underserved areas. AI-driven patient engagement tools, such as virtual assistants, chatbots, and automated reminders, enhance the telemedicine experience by providing all-day support and improving patient interactions outside of clinical visits. According to a 2022 survey by RockHealth Inc., stated that telemedicine gained 80% overall acceptance, making it the primary route for prescription treatment and mild illness.
AI-driven telemedicine systems can monitor patients' vital signs remotely and provide early warnings about potential health issues, ensuring continuous engagement between patients and their providers. Moreover, AI systems analyze large datasets from telemedicine interactions, generating insights that help healthcare providers optimize patient engagement strategies and improve overall outcomes. - Rising prevalence of chronic diseases: Chronic conditions such as diabetes, cardiovascular diseases, asthma, and hypertension require continuous monitoring, regular communication with healthcare providers, and proactive management, all of which can be facilitated by AI technologies. For instance, according to the International Diabetes Federation (IDF) Diabetes Atlas, as of 2021, 537 million adults (20-79 years) are living with diabetes, and the number is predicted to rise to 643 million by 2030 and 783 million by 2045. AI is helping healthcare systems implement comprehensive chronic care management (CCM) programs. These programs leverage AI to identify at-risk patients, deliver personalized health interventions, and ensure continuous engagement through automated tools and alerts. AI also helps streamline data collection and reporting, making CCM programs more efficient.
- Advancements in Natural Language Processing (NLP) and Machine Learning (ML): NLP and MI are pivotal in driving the growth of AI in patient engagement. These technologies are transforming how patients interact with healthcare systems, enhancing the experience and the effectiveness of care delivery. NLP enables AI-driven chatbots and virtual assistants to understand and respond to patient queries conversationally. These tools can handle routine inquiries, provide health education, schedule appointments, and answer questions about medications or treatments.
Recent advancements in NLP, particularly in understanding context, sentiment, and medical terminology, allow for more sophisticated, human-like interactions, making patients feel more supported and engaged. Apollo Hospitals has expanded its partnership with Google Cloud to put healthcare in the hands of every Indian through Apollo's digital platform, Apollo 24|7. Apollo 24|7 teams collaborated with Google Cloud to develop a Clinical Intelligence Engine (CIE) using Vertex AI and generative AI (gen AI) models. Apollo Hospitals is also looking into the usage of Med-PaLM 2, a Google-developed LLM that can answer medical queries and provide clinical text summaries.
ML algorithms, combined with NLP, can analyze a patient’s health history, preferences, and real-time data to offer personalized advice and reminders. ML models can recommend medication dosages, and lifestyle changes, or alert patients to potential risks based on their unique health profile. This level of personalization is crucial for maintaining engagement, particularly for patients managing chronic conditions.
Challenges
- High implantation and integration costs: Implementing AI-powered patient engagement systems often requires significant investment in technology infrastructure, including data integration, software development, and AI model training. For many healthcare providers, especially in resource-constrained settings, the cost of adopting these advanced systems may be prohibitive. Additionally, integrating AI solutions with existing electronic health records (EHR) systems or other healthcare platforms can be technically challenging and costly.
- Lack of standardization: The lack of standardization in AI algorithms, data formats, and healthcare interoperability can hinder the widespread use of AI in patient engagement. Different healthcare providers use different systems, and integrating AI tools across various platforms without common standards can result in inefficiencies, poor data sharing, and reduced effectiveness of AI solutions.
AI in Patient Engagement Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
19.4% |
|
Base Year Market Size (2025) |
USD 7.86 billion |
|
Forecast Year Market Size (2035) |
USD 46.29 billion |
|
Regional Scope |
|
AI in Patient Engagement Market Segmentation:
Software Type (Enhanced Communication, AI-powered Chatbots, Virtual Health assistants, Predictive Analytics Tools, and Patient Portal Solutions)
The enhanced communication segment is anticipated to dominate AI in patient engagement market share of over 34.3% by 2035. Enhanced communication, powered by AI, is crucial in patient engagement. AI-driven chatbots, virtual assistants, multilingual support, and personalized outreach transform patient-provider communication, helping healthcare organizations offer continuous, accessible, and meaningful interactions. By prioritizing enhanced communication, healthcare systems can boost patient engagement, improve satisfaction, and drive better health outcomes in an increasingly digital healthcare landscape.
Additionally, voice recognition advancements are making it easier for patients, especially those with disabilities or limited digital literacy, to interact with healthcare systems. Voice-activated AI tools allow patients to ask questions, receive health updates, and access their health data without needing to type, enhancing accessibility and engagement for a broader range of patients.
Deployment Mode (Cloud-based, Web-based, and On-premises)
By the end of 2035, cloud-based segment in the AI in patient engagement market is poised to account for significant revenue. By leveraging cloud technology, healthcare providers and organizations can streamline operations, enhance accessibility, and improve patient interactions more efficiently than ever before. Cloud-based AI solutions allow for centralized data storage and processing, making it easier to analyze patient data in real time and across platforms, which is vital for proactive and personalized care.
Cloud-based platforms can integrate data from multiple sources, including EHRs, wearables, and other digital health tools, offering a comprehensive view of the patient’s health for personalized care. Moreover, patients and providers can access cloud-based platforms from anywhere, fostering seamless communication and engagement through mobile devices or web portals.
Our in-depth analysis of the AI in patient engagement market includes the following segments:
|
Software Type |
|
|
Deployment Mode |
|
|
Application |
|
|
End use |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
AI in Patient Engagement Market Regional Analysis:
North America Market Forecast
North America industry is anticipated to hold largest revenue share of 38.5% by 2035. The market's growth is attributed to the growing demand for personalized healthcare, rising patient expectations for digital engagement, and technological advancements, including AI-powered chatbots, predictive analytics, and virtual assistants.
In the U.S. AI in patient engagement market’s growth is spurred by the high prevalence of chronic diseases in the country, which requires ongoing patient engagement for effective management. Additionally, an aging population is driving the demand for continuous health monitoring and support, leveraging AI-based tools for convenience and effectiveness. According to the Population Reference Bureau, the number of U.S. citizens 65 and older will rise from 58 million in 2022 to 82 million by 2050, a 47% increase, and their proportion of the population will increase from 17% to 23%. Moreover, leading key players, including Microsoft, Oracle, and IBM are investing in AI to enhance patient data analysis, enabling more precise and personalized care.
In Canada, the AI in patient engagement market is seeing growth driven by the increasing adoption of electronic health records, digital health tools, and supportive government initiatives. Health Canada has invested in several digital health programs to advance patient engagement, notably through the work of Canada Health Infoway, which establishes standards and provides funding to enhance digital health interoperability. The integration of AI tools has been especially beneficial in patient engagement functions such as appointment scheduling, health management, and remote consultations, which streamline patient interactions with the healthcare systems.
Europe Market Analysis
The Europe AI in patient engagement market is poised to register the fastest growth during the forecast period. The market is growing with major developments occurring in response to regulatory frameworks such as the EU’s General Data Protection Regulation (GDPR) and the forthcoming Artificial Intelligence Act. These regulations aim to enhance data privacy, transparency, and ethical AI usage in healthcare. Patient engagement tools powered by AI are being increasingly adopted to personalize care, assist in chronic disease management, and improve communication between healthcare providers and patients.
Leading markets within Europe include Germany, the UK, and France, where AI solutions are extensively used across various therapeutic areas such as mental health, cardiovascular care, and oncology.
In Germany, healthcare providers are increasingly adopting AI-based tools such as chatbots, natural language processing, and computer vision, which support patient interaction and engagement across both inpatient and outpatient settings. These tools enhance personalized care and help reduce administrative burdens by automating communication, billing, and patient education. The country’s focus on health data security and robust E&D investment is further fueling the adoption of AI to improve patient outcomes and experiences.
Key AI in Patient Engagement Market Players:
- Medadvisor Solutions
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Innovaccer, Inc.
- EnlivenHealth (a subdivision of Omnicell, Inc.)
- EmpiRx Health, LLC.
- IBM
- Huma
- mPulse Mobile
- AllazoHealth
- P360
- Brand Engagement Network, Inc.
Key players in the AI in patient engagement market are driving growth by focusing on a range of advanced technologies, strategic partnerships, and targeted solutions to meet evolving healthcare needs. The key players are also addressing administrative challenges, optimizing costs, and helping healthcare providers improve outcomes.
Here are some key players in the market:
Recent Developments
- In June 2024, MedAdvisor Solutions, the global leader in pharmacy-driven, patient engagement, announced the launch of Omnichannel Engagement for Pharmacy, which is powered by the company's AI-enabled platform, THRiV.
- In November 2023, Huma, a leading global digital health firm, and Merck KGaA, Darmstadt, Germany, a renowned scientific and technology corporation, announced a collaboration to create a digital solution that aims to assist cancer patients better understand and manage their diseases and treatments.
- Report ID: 6624
- Published Date: Aug 14, 2025
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Inquiry Before BuyingFrequently Asked Questions (FAQ)
AI in Patient Engagement Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
Copyright @ 2025 Research Nester. All Rights Reserved.
